{"id":"concomitant-therapy-14-days","safety":{"commonSideEffects":[{"rate":"0.1-0.5%","effect":"Increased risk of diabetic ketoacidosis"},{"rate":"1-5%","effect":"Increased risk of genital mycotic infections"},{"rate":"1-5%","effect":"Increased risk of urinary tract infections"},{"rate":"1-5%","effect":"Increased risk of hypotension"},{"rate":"0.1-1%","effect":"Increased risk of acute kidney injury"}]},"_chembl":{"chemblId":"CHEMBL267665","moleculeType":"Small molecule","molecularWeight":"285.30"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"The exact mechanism of action is through the inhibition of the sodium-glucose cotransporter 2 (SGLT2) in the kidneys, leading to reduced glucose reabsorption and increased glucose excretion in the urine. This results in improved glycemic control and weight loss in patients with type 2 diabetes.","oneSentence":"This drug is used to treat various conditions by inhibiting the reabsorption of sodium and water in the kidneys.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:43:42.621Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 2 diabetes"},{"name":"Heart failure"}]},"trialDetails":[{"nctId":"NCT02758951","phase":"PHASE2, PHASE3","title":"Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases","status":"ACTIVE_NOT_RECRUITING","sponsor":"Koen Rovers","startDate":"2017-06-01","conditions":"Colorectal Neoplasm, Colorectal Cancer, Colorectal Neoplasms Malignant","enrollment":358},{"nctId":"NCT04894643","phase":"NA","title":"Preoperative, Proton- Radiotherapy Combined With Chemotherapy for Borderline Resectable Pancreatic Cancer","status":"RECRUITING","sponsor":"EBG MedAustron GmbH","startDate":"2020-09-14","conditions":"Pancreatic Cancer, Proton Therapy","enrollment":10},{"nctId":"NCT06859424","phase":"PHASE2","title":"A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation","status":"RECRUITING","sponsor":"Center for International Blood and Marrow Transplant Research","startDate":"2025-07-25","conditions":"AML (Acute Myelogenous Leukemia), Acute Lymphoid Leukemia (ALL), Acute Leukemia (Category)","enrollment":358},{"nctId":"NCT07475585","phase":"NA","title":"Effects of Auricular Point Pressing With Pellets in Children With Insufficient Hyperopia Reserve","status":"NOT_YET_RECRUITING","sponsor":"Fangbiao Tao","startDate":"2026-03-30","conditions":"Myopia, Ear Acupressure Pellets, Hyperopia Reserve","enrollment":380},{"nctId":"NCT07472868","phase":"PHASE3","title":"Neoadjuvant FOLFOXIRI and Chemoradiotherapy Versus Neoadjuvant CAPOX/FOLFOX and Chemoradiotherapy Followed by Surgery or a Watch-and-Wait Approach in High Risk Locally Advanced Rectal Cancer","status":"NOT_YET_RECRUITING","sponsor":"J. W. A. Burger","startDate":"2026-03-03","conditions":"Locally Advanced Rectal Carcinoma","enrollment":394},{"nctId":"NCT06087536","phase":"PHASE2","title":"A Clinical Trial to Assess the Safety and PK of OMN6 in HABP or VABP Caused by Acinetobacter Baumannii Complex","status":"RECRUITING","sponsor":"Omnix Medical Ltd","startDate":"2026-03","conditions":"Hospital-acquired Bacterial Pneumonia, Ventilator-associated Bacterial Pneumonia","enrollment":54},{"nctId":"NCT04028570","phase":"NA","title":"A Feasibility Study Evaluating Surgery for Mesothelioma After Radiation Therapy Using Extensive Pleural Resection","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2019-09-05","conditions":"Mesothelioma; Lung","enrollment":15},{"nctId":"NCT07283094","phase":"PHASE1","title":"FHD-286 With Low-Dose Weekly Decitabine/Venetoclax in Patients With Acute Myeloid Leukemia","status":"RECRUITING","sponsor":"Montefiore Medical Center","startDate":"2026-02-03","conditions":"Acute Myeloid Leukemia, Myelodysplastic Syndrome","enrollment":33},{"nctId":"NCT07026474","phase":"PHASE3","title":"Re-Radiochemotherapy and Pembrolizumab vs. Immuno(Chemo)Therapy for Locoregionally Recurrent PD-L1 Positive (CPS≥1) HNSCC","status":"RECRUITING","sponsor":"Universität des Saarlandes","startDate":"2025-10-30","conditions":"Recurrent Head and Neck Squamous Cell Carcinoma","enrollment":214},{"nctId":"NCT06484491","phase":"NA","title":"IMPT Dose Escalation for NSCLC (HyDose)","status":"RECRUITING","sponsor":"University Medical Center Groningen","startDate":"2025-09-01","conditions":"Carcinoma, Non-Small-Cell Lung","enrollment":87},{"nctId":"NCT05864196","phase":"PHASE1","title":"Two Fraction Prostate SBRT With DIL SIB","status":"RECRUITING","sponsor":"NYU Langone Health","startDate":"2023-07-17","conditions":"Prostate Cancer","enrollment":80},{"nctId":"NCT06305182","phase":"PHASE2","title":"Metreleptin in Anorexia Nervosa","status":"RECRUITING","sponsor":"Gabriella Milos","startDate":"2024-05-31","conditions":"Anorexia Nervosa","enrollment":50},{"nctId":"NCT03977233","phase":"PHASE2","title":"Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer","status":"RECRUITING","sponsor":"UNC Lineberger Comprehensive Cancer Center","startDate":"2019-06-12","conditions":"Pancreatic Ductal Adenocarcinoma (PDAC), Cancer of Pancreas, Pancreatic Cancer, Adult","enrollment":45},{"nctId":"NCT07320235","phase":"PHASE1","title":"Imetelstat Combinations in Relapsed AML","status":"RECRUITING","sponsor":"Douglas Tremblay","startDate":"2026-01","conditions":"Relapsed Acute Myeloid Leukemia","enrollment":36},{"nctId":"NCT06835530","phase":"PHASE2","title":"A Combination of Rituximab and CC-99282 as Front-line Therapy for Older Frail Patients With Diffuse Large B-cells Non-Hodgkin Lymphoma Evaluated With a Simplified Geriatric Assessment (sGA): a Phase II Study of the Fondazione Italiana Linfomi (FIL)","status":"RECRUITING","sponsor":"Fondazione Italiana Linfomi - ETS","startDate":"2025-04-09","conditions":"Diffuse Large B Cell Non-Hodgkin Lymphoma","enrollment":47},{"nctId":"NCT07315035","phase":"PHASE2","title":"QL1706-SOX vs SOX Alone as Neoadjuvant Therapy for Resectable Diffuse-Type Gastric Cancer","status":"NOT_YET_RECRUITING","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2026-01-01","conditions":"Gastric Cancer Stage III","enrollment":74},{"nctId":"NCT05494190","phase":"NA","title":"The Management of Metastatic Neck Nodes in N2/3 Hypopharyngeal Squamous Cell Carcinoma","status":"RECRUITING","sponsor":"Eye & ENT Hospital of Fudan University","startDate":"2022-11-01","conditions":"Hypopharyngeal Carcinoma","enrollment":111},{"nctId":"NCT07297030","phase":"PHASE2","title":"SIB-RT Combined With CAPOX and PD-1 for High-Risk Rectal Cancer","status":"NOT_YET_RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2025-12-20","conditions":"Rectal Cancer","enrollment":37},{"nctId":"NCT04612751","phase":"PHASE1","title":"Phase 1b Study of Dato-DXd in Combination With Immunotherapy With or Without Carboplatin in Advanced or Metastatic Non-Small Cell Lung Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2021-02-02","conditions":"Advanced or Metastatic NSCLC","enrollment":155},{"nctId":"NCT03013998","phase":"PHASE1, PHASE2","title":"Study of Biomarker-Based Treatment of Acute Myeloid Leukemia","status":"RECRUITING","sponsor":"Beat AML, LLC","startDate":"2016-11","conditions":"Previously Untreated Relapsed Refractory Acute Myeloid Leukemia","enrollment":3000},{"nctId":"NCT02630615","phase":"","title":"Circulating Tumor Cells (CTC) in Lung Cancer","status":"RECRUITING","sponsor":"Shadia Jalal","startDate":"2017-10-19","conditions":"Lung Neoplasms","enrollment":80},{"nctId":"NCT07284277","phase":"PHASE1, PHASE2","title":"TTFields and Chemotherapy in Metastatic Pancreatic Adenocarcinoma (mPDAC)","status":"RECRUITING","sponsor":"Clinica Universidad de Navarra, Universidad de Navarra","startDate":"2025-10-14","conditions":"Pancreatic Adenocarcinoma Metastatic, Pancreatic Ductal Adenocarcinoma","enrollment":30},{"nctId":"NCT07281443","phase":"NA","title":"MDA and Targeted Control Against Plasmodium Carriage in the Sahel","status":"ACTIVE_NOT_RECRUITING","sponsor":"Institut de Recherche pour le Developpement","startDate":"2024-09-23","conditions":"Malaria, Falciparum, Malaria, Asymptomatic Parasitaemia","enrollment":18000},{"nctId":"NCT06751121","phase":"PHASE3","title":"Study to Evaluate the Efficacy and Safety of DWP14012-based Triple Therapy in Eradication of Helicobacter Pylori","status":"COMPLETED","sponsor":"Daewoong Pharmaceutical Co. LTD.","startDate":"2024-02-06","conditions":"Helicobacter Pylori Infection, Helicobacter Pylori Infected Patients, Helicobacter Pylori Infected Subjects","enrollment":461},{"nctId":"NCT05623397","phase":"","title":"A Deep Learning Method to Evaluate QT on Ribociclib","status":"COMPLETED","sponsor":"CMC Ambroise Paré","startDate":"2023-07-28","conditions":"Breast Cancer, Ribociclib","enrollment":70},{"nctId":"NCT05433116","phase":"PHASE2","title":"Pembrolizumab and Lenvatinib After Definitive Chemoradiation of Locally Advanced HNSCC","status":"ACTIVE_NOT_RECRUITING","sponsor":"Universität des Saarlandes","startDate":"2023-05-25","conditions":"Head and Neck Squamous Cell Carcinoma","enrollment":50},{"nctId":"NCT07238686","phase":"PHASE2","title":"Venetoclax-containing Therapy Combined With Microtransplant for Intermediate-risk and Higher MDS","status":"RECRUITING","sponsor":"Beijing 302 Hospital","startDate":"2025-06-20","conditions":"Myelodysplastic Syndromes","enrollment":40},{"nctId":"NCT07239466","phase":"PHASE2","title":"A Pilot Study Evaluating β-hydroxybutyrate Supplementation Concomitant to Short-Course Radiotherapy Followed by Immunotherapy Combined With CAPEOX Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer","status":"NOT_YET_RECRUITING","sponsor":"Tao Zhang","startDate":"2026-01-01","conditions":"Rectal Cancer, Radiotherapy, Immunotherapy","enrollment":48},{"nctId":"NCT03904043","phase":"NA","title":"Non-Operative Management and Early Response Assessment in Rectal Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2020-07-01","conditions":"Adenocarcinoma of the Lower Rectum","enrollment":63},{"nctId":"NCT04459715","phase":"PHASE3","title":"A Study of Xevinapant (Debio 1143) in Combination With Platinum-Based Chemotherapy and Standard Fractionation Intensity-Modulated Radiotherapy in Participants With Locally Advanced Squamous Cell Carcinoma of the Head and Neck, Suitable for Definitive Chemoradiotherapy (TrilynX)","status":"TERMINATED","sponsor":"EMD Serono Research & Development Institute, Inc.","startDate":"2020-08-07","conditions":"Squamous Cell Carcinoma of the Head and Neck","enrollment":730},{"nctId":"NCT06086704","phase":"PHASE2","title":"Study of 18F-FFNP Breast PET/MRI","status":"RECRUITING","sponsor":"University of Wisconsin, Madison","startDate":"2024-09-25","conditions":"Breast Cancer","enrollment":53},{"nctId":"NCT05811624","phase":"NA","title":"Lifestyle Intervention in Overweight/Obese Chronic Low Back Pain (CLBP) Patients: an International Multi-center RCT","status":"RECRUITING","sponsor":"Vrije Universiteit Brussel","startDate":"2023-04-13","conditions":"Overweight or Obesity, Chronic Low-back Pain","enrollment":252},{"nctId":"NCT04158362","phase":"PHASE3","title":"Endocrine Therapy With Abemaciclib or Chemotherapy as Initial Metastatic Treatment in ER+/HER2- Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"UNICANCER","startDate":"2020-06-11","conditions":"Cancer Metastatic","enrollment":180},{"nctId":"NCT06443502","phase":"PHASE3","title":"A Study to Learn About the Safety of Vedolizumab and How Well it Works in Children and Teenagers With Active Chronic Pouchitis","status":"RECRUITING","sponsor":"Takeda","startDate":"2024-11-19","conditions":"Pouchitis","enrollment":30},{"nctId":"NCT07177443","phase":"PHASE3","title":"Serplulimab Combined With Induction Chemotherapy and Radiotherapy in Nasopharyngeal Carcinoma","status":"NOT_YET_RECRUITING","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2025-09-25","conditions":"Locally Advanced Nasopharyngeal Carcinoma","enrollment":456},{"nctId":"NCT06282315","phase":"PHASE3","title":"Real World Evaluation of an Albendazole-Ivermectin Coformulation Safety and Effectiveness","status":"RECRUITING","sponsor":"Insud Pharma","startDate":"2025-09-01","conditions":"Soil-Transmitted Helminths","enrollment":20000},{"nctId":"NCT07000162","phase":"PHASE2","title":"LAttice Radiation Therapy for Large Lesions: Reggio Emilia Single-arm Phase II Trial","status":"RECRUITING","sponsor":"Azienda USL Reggio Emilia - IRCCS","startDate":"2025-05-26","conditions":"Cancer, Palliative Radiotherapy","enrollment":56},{"nctId":"NCT07007806","phase":"PHASE1","title":"Drug-drug Interaction Study of Omeprazole and Bemnifosbuvir/Ruzasvir","status":"COMPLETED","sponsor":"Atea Pharmaceuticals, Inc.","startDate":"2025-05-09","conditions":"Healthy Volunteer Study","enrollment":20},{"nctId":"NCT04332848","phase":"PHASE4","title":"Susceptibility Testing Guided Versus Empirical Therapy for Refractory H. Pylori Infection","status":"RECRUITING","sponsor":"National Taiwan University Hospital","startDate":"2020-07-28","conditions":"Helicobacter Pylori Infection","enrollment":360},{"nctId":"NCT07101627","phase":"PHASE2","title":"A Prospective, Multicenter Clinical Study of Hetrombopag in the Prevention of Thrombocytopenia Caused by Lung Cancer Therapy","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Pulmonary Hospital, Shanghai, China","startDate":"2025-08-01","conditions":"Lung Cancer","enrollment":149},{"nctId":"NCT04879368","phase":"PHASE3","title":"RegoNivo vs Standard of Care Chemotherapy in AGOC","status":"ACTIVE_NOT_RECRUITING","sponsor":"Australasian Gastro-Intestinal Trials Group","startDate":"2021-06-01","conditions":"Gastro-Oesophageal Cancer","enrollment":450},{"nctId":"NCT07063888","phase":"PHASE2","title":"A Prospective Phase II Study of Postoperative Concurrent Chemoradiotherapy in Patients With Intrahepatic Cholangiocarcinoma","status":"RECRUITING","sponsor":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","startDate":"2025-05-16","conditions":"Intrahepatic Cholangiocarcinoma (Icc), Adjuvant Chemoradiotherapy, Narrow Margin","enrollment":66},{"nctId":"NCT01804790","phase":"PHASE3","title":"Efficacy of Neoadjuvant Folfirinox Regimen in Patients With Resectable Locally Advanced Rectal Cancer","status":"COMPLETED","sponsor":"UNICANCER","startDate":"2012-01","conditions":"Cancer of the Rectum","enrollment":461},{"nctId":"NCT03612791","phase":"PHASE2","title":"Trial Assessing the Inhibitor of Programmed Cell Death Ligand 1 (PD-L1) Immune Checkpoint Atezolizumab","status":"COMPLETED","sponsor":"Gustave Roussy, Cancer Campus, Grand Paris","startDate":"2018-08-13","conditions":"Locally Advanced Cervical Cancer","enrollment":189},{"nctId":"NCT03527264","phase":"PHASE2","title":"BrUOG 355: Nivolumab to Tailored Radiation Therapy With Concomitant Cisplatin in the Treatment of Patients With Cervical Cancer","status":"TERMINATED","sponsor":"Brown University","startDate":"2018-11-08","conditions":"Cervical Cancer","enrollment":4},{"nctId":"NCT06246344","phase":"","title":"Adaptive Boost Radiotherapy to Primary Lesions and Positive Nodes in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer","status":"RECRUITING","sponsor":"Shandong Cancer Hospital and Institute","startDate":"2023-12-01","conditions":"Rectal Cancer","enrollment":128},{"nctId":"NCT03721757","phase":"PHASE2","title":"CA209-891: Neoadjuvant and Adjuvant Nivolumab as Immune Checkpoint Inhibition in Oral Cavity Cancer","status":"COMPLETED","sponsor":"The Clatterbridge Cancer Centre NHS Foundation Trust","startDate":"2019-05-10","conditions":"Squamous Cell Carcinoma of the Oral Cavity","enrollment":21},{"nctId":"NCT06568406","phase":"NA","title":"Impact of Early Physiotherapy on Pain, Quality of Life, Pelvic Floor Function, and Sexual Health Post-Episiotomy","status":"RECRUITING","sponsor":"Brno University Hospital","startDate":"2024-10-01","conditions":"Gynecological; Surgery (Previous), Causing Obstructed Labor","enrollment":250},{"nctId":"NCT02770222","phase":"PHASE1","title":"A Clinical Study to Investigate the Effect of Gemfibrozil or Rifampicin on Blood Concentrations of Selexipag in Healthy Subjects","status":"COMPLETED","sponsor":"Actelion","startDate":"2016-06","conditions":"Healthy Subjects","enrollment":40},{"nctId":"NCT01814813","phase":"PHASE2","title":"Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery","status":"TERMINATED","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2013-06-19","conditions":"Recurrent Glioblastoma, Recurrent Adult Brain Tumor, Gliosarcoma","enrollment":90},{"nctId":"NCT05698771","phase":"PHASE1","title":"NAD-brain: a Pharmacokinetic Study of NAD Replenishment Therapy","status":"COMPLETED","sponsor":"Haukeland University Hospital","startDate":"2022-09-17","conditions":"Healthy","enrollment":12},{"nctId":"NCT06776744","phase":"NA","title":"EMpower Parents: Effectiveness of EMDR Treatment for Parental PTSD Related to Their Child's Medical Condition.","status":"NOT_YET_RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2025-01","conditions":"All Acute Pediatric Conditions, All Chronic Pediatric Conditions","enrollment":60},{"nctId":"NCT04281576","phase":"NA","title":"Effect of Tumor Treating Fields (TTFields, 150 KHz) Concomitant with Chemotherapy As First Line Treatment of Unresectable Gastroesophageal Junction or Gastric Adenocarcinoma","status":"COMPLETED","sponsor":"NovoCure Ltd.","startDate":"2019-12-19","conditions":"Gastric Cancer, GastroEsophageal Cancer","enrollment":28},{"nctId":"NCT05475431","phase":"","title":"Real-world Treatment of H. Pylori Eradication in Patients with Comorbidity","status":"COMPLETED","sponsor":"National Cheng-Kung University Hospital","startDate":"2020-05-06","conditions":"Helicobacter Pylori Infection, Comorbidities and Coexisting Conditions, Real-world Outcome","enrollment":1053},{"nctId":"NCT00868491","phase":"PHASE2","title":"Induction Chemotherapy Followed by Chemoradiation With Cetuximab in Head and Neck Cancer","status":"COMPLETED","sponsor":"Institute of Oncology Ljubljana","startDate":"2008-03","conditions":"Head and Neck Cancer","enrollment":30},{"nctId":"NCT06595186","phase":"PHASE2","title":"JK-1201I Combined with Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma Multiforme (GBM)","status":"RECRUITING","sponsor":"JenKem Technology Co., Ltd.","startDate":"2022-10-31","conditions":"Glioblastoma Multiforme (GBM)","enrollment":25},{"nctId":"NCT04553471","phase":"NA","title":"Palliative Lattice Stereotactic Body Radiotherapy (SBRT) for Patients With Sarcoma, Thoracic, Abdominal, and Pelvic Cancers","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2020-09-22","conditions":"Sarcoma, Thoracic Cancer, Abdominal Cancer","enrollment":70},{"nctId":"NCT03940586","phase":"PHASE2","title":"Letermovir Treatment in Pediatric Participants Following Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) (MK-8228-030)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2019-08-08","conditions":"Cytomegalovirus (CMV) Infection","enrollment":65},{"nctId":"NCT05478876","phase":"NA","title":"Carbon Ion Radiation Therapy in the Treatment of Mucous Melanomas of the Female Lower Genital Tract","status":"RECRUITING","sponsor":"CNAO National Center of Oncological Hadrontherapy","startDate":"2020-09-03","conditions":"Malignant Melanoma, Gynecologic Cancer","enrollment":9},{"nctId":"NCT05482451","phase":"EARLY_PHASE1","title":"Nivolumab and All-trans Retinoic Acid for Pancreatic Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"China Medical University Hospital","startDate":"2021-03-01","conditions":"Effect of Drug","enrollment":10},{"nctId":"NCT05444218","phase":"NA","title":"Surgical Access Combined With Systematically Administered Antibiotics in the Treatment of Peri-implantitis","status":"COMPLETED","sponsor":"University of Guarulhos","startDate":"2021-05-01","conditions":"Peri-Implantitis","enrollment":89},{"nctId":"NCT02085148","phase":"PHASE1","title":"A Phase I Dose Finding Study in Children With Solid Tumors Recurrent or Refractory to Standard Therapy","status":"COMPLETED","sponsor":"Bayer","startDate":"2014-04-11","conditions":"Pediatric Oncology","enrollment":62},{"nctId":"NCT00589875","phase":"PHASE2","title":"Phase 2a Study of CAN-2409 With Standard Radiation Therapy for Malignant Glioma","status":"COMPLETED","sponsor":"Candel Therapeutics, Inc.","startDate":"2007-03","conditions":"Malignant Glioma, Glioblastoma Multiforme, Anaplastic Astrocytoma","enrollment":52},{"nctId":"NCT06329934","phase":"NA","title":"Refined Nursing in Rehabilitation Training","status":"COMPLETED","sponsor":"Xinxiang Central Hospital","startDate":"2022-05-01","conditions":"Brain Injuries","enrollment":96},{"nctId":"NCT05389800","phase":"NA","title":"Pre- and Post-Operative Exercise in Patients With Hip Fracture","status":"NOT_YET_RECRUITING","sponsor":"National and Kapodistrian University of Athens","startDate":"2024-07","conditions":"Hip Fractures","enrollment":116},{"nctId":"NCT06304987","phase":"PHASE2","title":"Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and PCSK9 Inhibitor for pMMR/MSS Locally Advanced Mid-low Rectal Cancer","status":"NOT_YET_RECRUITING","sponsor":"Beijing Friendship Hospital","startDate":"2024-04","conditions":"Locally Advanced Rectal Cancer","enrollment":50},{"nctId":"NCT03378271","phase":"NA","title":"Accuracy and Treatment Experience of Two Glucose Monitoring Systems Tested in Patients With Type 1 Diabetes and Renal Impairment","status":"COMPLETED","sponsor":"Vastra Gotaland Region","startDate":"2016-05-05","conditions":"Diabetes Mellitus Complication, Renal Impairment","enrollment":40},{"nctId":"NCT05232630","phase":"PHASE4","title":"Fenfluramine for the Treatment of Different Types of Developmental and Epileptic Encephalopathies: a Pilot Trial Exploring Epileptic and Non-epileptic Outcomes","status":"UNKNOWN","sponsor":"Hospital Ruber Internacional","startDate":"2022-10-20","conditions":"Refractory Epilepsy, SYNGAP1 Encephalopathy, STXBP1 Encephalopathy With Epilepsy","enrollment":20},{"nctId":"NCT05912075","phase":"PHASE1","title":"Preoperative Radiotherapy And ASTX660 in Rectum Cancer","status":"RECRUITING","sponsor":"Gustave Roussy, Cancer Campus, Grand Paris","startDate":"2023-12-19","conditions":"Locally-advanced Rectal Cancer","enrollment":78},{"nctId":"NCT04498715","phase":"NA","title":"Trochanteric Femur Fracture Operated With Dynamic Hip Screw System (DHS) Augmented With a Biphasic Apatite Sulphate Combined With Systemic or Local Bisphosphonate","status":"UNKNOWN","sponsor":"Lithuanian University of Health Sciences","startDate":"2021-06-01","conditions":"Trochanteric Fracture of Femur","enrollment":20},{"nctId":"NCT06211543","phase":"","title":"Letermovir (LMV) Prophylaxis in CMV-seronegative Allogeneic Stem Cell Transplant Recipients With CMV Seropositive Donors: an Exploratory Study From Spanish GETH/TC Centers","status":"NOT_YET_RECRUITING","sponsor":"Grupo Espanol de trasplantes hematopoyeticos y terapia celular","startDate":"2024-03-30","conditions":"CMV","enrollment":80},{"nctId":"NCT04678973","phase":"NA","title":"Brief mHealth Self-Compassion Intervention on Internalized Weight Bias","status":"COMPLETED","sponsor":"Duke University","startDate":"2021-01-01","conditions":"Obesity, Stigma, Social","enrollment":80},{"nctId":"NCT02539537","phase":"PHASE3","title":"A Randomized Phase III Trial Comparing Folfirinox to Gemcitabine in Locally Advanced Pancreatic Carcinoma","status":"COMPLETED","sponsor":"UNICANCER","startDate":"2015-10-23","conditions":"Pancreatic Cancer, Carcinoma","enrollment":171},{"nctId":"NCT05923528","phase":"NA","title":"Comparison of Non-pharmaceutical Treatments for Evaporative Dry Eye","status":"UNKNOWN","sponsor":"He Eye Hospital","startDate":"2023-11-01","conditions":"Dry Eye","enrollment":116},{"nctId":"NCT04888741","phase":"PHASE2","title":"Methods of T Cell Depletion Trial (MoTD)","status":"UNKNOWN","sponsor":"University of Birmingham","startDate":"2021-02-22","conditions":"Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelomonocytic Leukemia","enrollment":400},{"nctId":"NCT04119674","phase":"PHASE1, PHASE2","title":"Pilot Study of Anlotinib With STUPP Regimen for Patients With Newly Diagnosed Glioblastoma","status":"COMPLETED","sponsor":"Zhejiang Cancer Hospital","startDate":"2019-03-19","conditions":"Glioblastoma","enrollment":33},{"nctId":"NCT00638612","phase":"PHASE1","title":"AdV-tk Therapy With Surgery and Chemoradiation for Pancreas Cancer (PaTK01)","status":"COMPLETED","sponsor":"Candel Therapeutics, Inc.","startDate":"2008-08","conditions":"Pancreatic Adenocarcinoma, Pancreatic Cancer","enrollment":27},{"nctId":"NCT03273972","phase":"NA","title":"INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers","status":"COMPLETED","sponsor":"Cambridge University Hospitals NHS Foundation Trust","startDate":"2017-09-07","conditions":"Atherosclerosis, Cardiovascular Diseases","enrollment":30},{"nctId":"NCT00318903","phase":"PHASE2","title":"Irinotecan and Taxotere With Radiotherapy as Preoperative Treatment in Resectable Esophageal Cancer","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2002-01","conditions":"Esophageal Cancer, Cancer of the Esophagus, Esophagus Cancer","enrollment":25},{"nctId":"NCT05211219","phase":"NA","title":"The Role of Probiotics in Periodontal Disease","status":"COMPLETED","sponsor":"Gazi University","startDate":"2021-01-07","conditions":"Periodontal Diseases","enrollment":36},{"nctId":"NCT04683354","phase":"PHASE1","title":"Study of HL-085 in Patients With Advanced Solid Tumor Tumors","status":"COMPLETED","sponsor":"Kechow Pharma, Inc.","startDate":"2020-12-23","conditions":"Solid Tumor, Adult","enrollment":28},{"nctId":"NCT03620162","phase":"PHASE3","title":"A Study to Evaluate the Interchangeability of V114 and Prevnar 13™ in Healthy Infants (V114-027/PNEU-DIRECTION)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2018-10-18","conditions":"Pneumococcal Infections","enrollment":900},{"nctId":"NCT04297748","phase":"PHASE1, PHASE2","title":"Bioimaging Study of 89Zr-M7824 in NSCLC","status":"TERMINATED","sponsor":"Olivia Newton-John Cancer Research Institute","startDate":"2020-06-01","conditions":"Non-Small Cell Lung Cancer","enrollment":5},{"nctId":"NCT03245229","phase":"PHASE1","title":"A Study in Healthy Male Subjects to Investigate Whether Administration of ACT-132577 Can Affect Rosuvastatin's Fate in the Body (Amount and Time of Presence in the Blood)","status":"COMPLETED","sponsor":"Idorsia Pharmaceuticals Ltd.","startDate":"2017-08-10","conditions":"Healthy Subjects","enrollment":20},{"nctId":"NCT03392909","phase":"PHASE1, PHASE2","title":"Intravenous Gentamicin Therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB)","status":"UNKNOWN","sponsor":"University of Southern California","startDate":"2018-07-05","conditions":"Recessive Dystrophic Epidermolysis Bullosa","enrollment":9},{"nctId":"NCT05449028","phase":"NA","title":"Helicobacter Pylori Eradication Therapy in Portugal","status":"UNKNOWN","sponsor":"Unidade Local de Saúde de Coimbra, EPE","startDate":"2022-05-01","conditions":"Helicobacter Pylori, Gut Microbiota, Immunology","enrollment":230},{"nctId":"NCT02022098","phase":"NA","title":"Debio 1143-201 Dose-finding and Efficacy Phase I/II Trial","status":"COMPLETED","sponsor":"Debiopharm International SA","startDate":"2013-10","conditions":"Squamous Cell Carcinoma of the Head and Neck","enrollment":144},{"nctId":"NCT00777491","phase":"PHASE2","title":"Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery","status":"COMPLETED","sponsor":"Radiation Therapy Oncology Group","startDate":"2008-12","conditions":"Bladder Cancer","enrollment":70},{"nctId":"NCT05378919","phase":"PHASE2","title":"Neoadjuvant Therapy vs Standard Therapy in Locally Advanced Rectal Cancer","status":"RECRUITING","sponsor":"Lithuanian University of Health Sciences","startDate":"2015-06-01","conditions":"Neoadjuvant Therapy in Rectal Cancer, Radiotherapy, FOLFOX","enrollment":250},{"nctId":"NCT04984525","phase":"PHASE1","title":"Safety and Tolerability of SYNB1934 in Healthy Adult Volunteers","status":"COMPLETED","sponsor":"Synlogic","startDate":"2021-07-02","conditions":"Healthy","enrollment":106},{"nctId":"NCT05282719","phase":"PHASE2","title":"Clinical Study of Venetoclax Combined With Azacytiside in the Treatment of Myelodysplastic/Myeloproliferative Neoplasms in Adults","status":"UNKNOWN","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2022-04","conditions":"Myelodysplastic/Myeloproliferative Neoplasms, Adult","enrollment":33},{"nctId":"NCT01059188","phase":"PHASE2","title":"Neo-adjuvant Treatment in Non-Small Cell Lung Cancer (NSCLC)","status":"COMPLETED","sponsor":"Swiss Cancer Institute","startDate":"2010-05-03","conditions":"Lung Cancer","enrollment":69},{"nctId":"NCT04537078","phase":"PHASE3","title":"Progestin Primed Double Stimulation Protocol Versus Flexible GnRH Antagonist Protocol in Poor Responders","status":"COMPLETED","sponsor":"El Shatby University Hospital for Obstetrics and Gynecology","startDate":"2020-09-01","conditions":"Infertility, Female","enrollment":90},{"nctId":"NCT04507321","phase":"PHASE1","title":"Pharmacokinetics and Metabolism of 14 Carbon [14C]-GSK3640254","status":"COMPLETED","sponsor":"ViiV Healthcare","startDate":"2020-09-24","conditions":"HIV Infections","enrollment":5},{"nctId":"NCT01308034","phase":"PHASE1","title":"Study of Continuous Dosing of Sunitinib in Non GIST Sarcomas With Concomitant Radiotherapy","status":"COMPLETED","sponsor":"Centre Leon Berard","startDate":"2011-03","conditions":"Non GIST Sarcomas","enrollment":25},{"nctId":"NCT05126121","phase":"NA","title":"Efficacy and Safety of 14-day Concomitant Therapy for Difficult-to-Treat Helicobacter Pylori Infection","status":"UNKNOWN","sponsor":"Xiuli Zuo","startDate":"2021-11-20","conditions":"Helicobacter Pylori Infection","enrollment":60},{"nctId":"NCT05140616","phase":"PHASE1, PHASE2","title":"Study of Chidamide for Steroid-resistant/Steroid-dependent Severe cGVHD","status":"UNKNOWN","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2021-05-31","conditions":"Safety and Efficacy","enrollment":20},{"nctId":"NCT05133193","phase":"NA","title":"Efficacy and Safety of 14-day Concomitant Therapy for Refractory Helicobacter Pylori Infection","status":"UNKNOWN","sponsor":"Shandong University","startDate":"2021-11-20","conditions":"Helicobacter Pylori Infection","enrollment":60},{"nctId":"NCT04133415","phase":"NA","title":"Palliative Lattice Stereotactic Body Radiotherapy (SBRT)","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2019-10-31","conditions":"Cancer, Palliative Radiotherapy","enrollment":20},{"nctId":"NCT03548090","phase":"NA","title":"The Effects of Plantar Flexion Training in People With Chronic Stroke","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2018-10-01","conditions":"Stroke, Hemiplegic Gait","enrollment":15}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Concomitant therapy 14 days","genericName":"Concomitant therapy 14 days","companyName":"Incheon St.Mary's Hospital","companyId":"incheon-st-mary-s-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This drug is used to treat various conditions by inhibiting the reabsorption of sodium and water in the kidneys. Used for Type 2 diabetes, Heart failure.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}